share_log

US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results

US Stocks Edge Lower; EchoStar Shares Tumble After Q2 Results

美股微跌;回聲星通信公佈第二季度業績後股價下跌。
Benzinga ·  08/09 12:29

U.S. stocks traded lower midway through trading, with the Dow Jones falling around 0.1% on Friday.

美國股市下午交易時出現下跌,道瓊斯週五下跌約0.1%。

The Dow traded down 0.12% to 39,399.04 while the NASDAQ fell 0.20% to 16,626.36. The S&P 500 also fell, dropping, 0.02% to 5,318.02.

道瓊斯下跌0.12%至39,399.04,納斯達克下跌0.20%至16,626.36。標準普爾500指數也下跌了0.02%至5,318.02。

Leading and Lagging Sectors
Health care shares climbed by 0.3% on Friday.

領漲與跌幅最大的板塊:
醫療保健股票週五上漲0.3%。

In trading on Friday, communication services shares fell 0.6%.

在週五的交易中,通訊服務股票下跌了0.6%。

Top Headline

頭條新聞:

Shares of EchoStar Corporation (NASDAQ:SATS) dipped around 16% on Friday after the company reported worse-than-expected second-quarter financial results..

回聲星通信(NASDAQ:新翔集團)的股票週五下跌約16%,因爲該公司報告的第二季度財務業績低於預期。

The company reported a second-quarter loss per share of 76 cents, which missed the street view of 17 cents loss. Quarterly revenues of $3.953 billion missed the analyst consensus of $3.983 billion.

該公司報告的第二季度每股虧損爲76美分,不及華爾街預期的每股虧損17美分。季度營收爲39.53億美元,低於分析師共識的39.83億美元。

Equities Trading UP

股票上漲:

  • FSD Pharma Inc. (NASDAQ:HUGE) shares shot up 227% to $0.2995.
  • Shares of Iteris, Inc. (NASDAQ:ITI) got a boost, surging 63% to $6.98 after the company announced it will be acquired by Almaviva for $335 million.
  • Hyzon Motors Inc. (NASDAQ:HYZN) shares were also up, gaining 36% to $0.1167. Hyzon will host a conference call to discuss its second quarter earnings results on Tuesday, Aug. 13.
  • FSD Pharma(NASDAQ:fsd pharma)股票飆升227%,至0.2995美元。
  • Iteris,Inc.(NASDAQ:ITI)股票受到提振,大漲63%,至6.98美元,因爲該公司宣佈將被Almaviva收購,收購價爲33500萬美元。
  • Hyzon Motors Inc. (NASDAQ:HYZN)股票也上漲了36%,至0.1167美元。Hyzon將在8月13日星期二舉行電話會議,討論其第二季度業績。

Equities Trading DOWN

股票下跌:

  • AN2 Therapeutics, Inc. (NASDAQ:ANTX) shares dropped 60% to $1.05 after the company announced that it will discontinue its EBO-301 study following topline results from its Phase 2 part of the study in treatment-refractory patients with MAC lung disease.
  • Shares of Vicinity Motor Corp. (NASDAQ:VEV) were down 56% to $0.1335. Vicinity Motor will release financial results for the second quarter, after the closing bell on Wednesday, Aug. 14.
  • Meta Materials Inc. (NASDAQ:MMAT) was down, falling 50% to $1.0340 after the company disclosed in an SEC filing that it ceased operations and filed a voluntary petition for relief under the provisions of Chapter 7 of Title 11 in the US Bankruptcy Court.
  • AN2 Therapeutics,Inc.(NASDAQ:ANTX)股票下跌60%,至1.05美元,因爲該公司宣佈將停止EBO-301研究,根據研究治療難治性MAC肺部疾病患者的二期研究的頭部結果。
  • Vicinity Motor Corp.(NASDAQ:VEV)的股票下跌了56%,至0.1335美元。Vicinity Motor將在8月14日收盤後發佈第二季度業績。
  • Meta Materials Inc.(NASDAQ:MMAT)股票下跌了50%,至1.0340美元,因爲該公司在提交的一份SEC文件中披露,已停止運營,並根據美國破產法第11章的規定自願申請破產救濟。

Commodities
In commodity news, oil traded up 0.6% to $76.61 while gold traded up 0.3% at $2,470.40.

商品雜項
在商品新聞中,油價上漲了0.6%,至76.61美元,而黃金價格上漲了0.3%,至2,470.40美元。

Silver traded down 0.5% to $27.48 on Thursday, while copper rose 0.9% to $3.9930.

銀價週四下跌了0.5%,至27.48美元,而銅價上漲了0.9%,至3.9930美元。

Euro zone

歐元區:

European shares were higher today. The eurozone's STOXX 600 rose 0.57%, Germany's DAX rose 0.24% and France's CAC 40 rose 0.31%. Spain's IBEX 35 Index rose 0.76%, while London's FTSE 100 rose 0.28%.

歐洲股市今天上漲。歐元區STOXX 600上漲了0.57%,德國DAX上漲了0.24%,法國CAC 40上漲了0.31%。西班牙IBEX 35指數上漲了0.76%,而倫敦富時100指數上漲了0.28%。

Asia Pacific Markets

亞太市場

Asian markets closed mixed on Friday, with Japan's Nikkei 225 gaining 0.56%, Hong Kong's Hang Seng Index gaining 1.17%, China's Shanghai Composite Index falling 0.27% and S&P BSE Sensex gaining 1.04%.

週五,亞洲市場表現不一,日本的日經225指數上漲了0.56%,香港的恒生指數上漲了1.17%,中國的上證綜指下跌了0.27%,印度的S&P BSE Sensex上漲了1.04%。

Economics

經濟學

The Baker Hughes rig count report for the latest week will be released today.

貝克休斯鑽井報告最新一週將於今天發佈。

Now Read This:

現在閱讀這個:

  • Top 3 Utilities Stocks That Could Lead To Your Biggest Gains This Month
  • 前三家公用事業股票能夠引領您本月最大的獲利。
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論